Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 4
2015 2
2017 1
2018 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

7 results
Results by year
Filters applied: . Clear all
Page 1
AID/APOBEC deaminases and cancer.
Rebhandl S, Huemer M, Greil R, Geisberger R. Rebhandl S, et al. Oncoscience. 2015 Apr 28;2(4):320-33. doi: 10.18632/oncoscience.155. eCollection 2015. Oncoscience. 2015. PMID: 26097867 Free PMC article. Review.
APOBEC3 signature mutations in chronic lymphocytic leukemia.
Rebhandl S, Huemer M, Gassner FJ, Zaborsky N, Hebenstreit D, Catakovic K, Grössinger EM, Greil R, Geisberger R. Rebhandl S, et al. Leukemia. 2014 Sep;28(9):1929-32. doi: 10.1038/leu.2014.160. Epub 2014 May 20. Leukemia. 2014. PMID: 24840555 Free PMC article. No abstract available.
Imprecision and DNA Break Repair Biased towards Incompatible End Joining in Leukemia.
Gassner FJ, Schubert M, Rebhandl S, Spandl K, Zaborsky N, Catakovic K, Blaimer S, Hebenstreit D, Greil R, Geisberger R. Gassner FJ, et al. Mol Cancer Res. 2018 Mar;16(3):428-438. doi: 10.1158/1541-7786.MCR-17-0373. Epub 2017 Dec 8. Mol Cancer Res. 2018. PMID: 29222170 Free PMC article.
AIDing cancer treatment: Reducing AID activity via HSP90 inhibition.
Rebhandl S, Geisberger R. Rebhandl S, et al. Eur J Immunol. 2015 Aug;45(8):2208-11. doi: 10.1002/eji.201545832. Epub 2015 Jul 7. Eur J Immunol. 2015. PMID: 26151367 Free PMC article.
AID induces intraclonal diversity and genomic damage in CD86(+) chronic lymphocytic leukemia cells.
Huemer M, Rebhandl S, Zaborsky N, Gassner FJ, Hainzl S, Weiss L, Hebenstreit D, Greil R, Geisberger R. Huemer M, et al. Eur J Immunol. 2014 Dec;44(12):3747-57. doi: 10.1002/eji.201344421. Epub 2014 Oct 18. Eur J Immunol. 2014. PMID: 25179679 Free PMC article. Clinical Trial.
Chemotherapy-induced augmentation of T cells expressing inhibitory receptors is reversed by treatment with lenalidomide in chronic lymphocytic leukemia.
Gassner FJ, Zaborsky N, Neureiter D, Huemer M, Melchardt T, Egle A, Rebhandl S, Catakovic K, Hartmann TN, Greil R, Geisberger R. Gassner FJ, et al. Haematologica. 2014 May;99(5):67-9. doi: 10.3324/haematol.2013.098459. Epub 2014 Feb 21. Haematologica. 2014. PMID: 24561794 Free PMC article. No abstract available.
Alternative splice variants of AID are not stoichiometrically present at the protein level in chronic lymphocytic leukemia.
Rebhandl S, Huemer M, Zaborsky N, Gassner FJ, Catakovic K, Felder TK, Greil R, Geisberger R. Rebhandl S, et al. Eur J Immunol. 2014 Jul;44(7):2175-87. doi: 10.1002/eji.201343853. Epub 2014 Apr 15. Eur J Immunol. 2014. PMID: 24668151 Free PMC article.
Feedback